...
首页> 外文期刊>Current molecular medicine >Repurposing of Fluvastatin Against Candida albicans CYP450 Lanosterol 14 alpha-demethylase, a Target Enzyme for Antifungal Therapy: An In silico and In vitro Study
【24h】

Repurposing of Fluvastatin Against Candida albicans CYP450 Lanosterol 14 alpha-demethylase, a Target Enzyme for Antifungal Therapy: An In silico and In vitro Study

机译:氟伐他汀对Candida albicans Cyp450 Lanterol醇14α-脱甲基酶,抗真菌治疗的靶酶的重新抑制:在硅和体外研究中

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: The incidence of fungal infections has increased significantly. Specifically the cases of candida albicans infection are increasing day by day and their resistance to clinically approved drugs is a major concern for humans. Various classes of antifungal drugs are available in the market for the treatment of these infections but unfortunately, none of them is able to treat the infection.
机译:背景:真菌感染的发病率显着增加。 具体而言,念珠菌白醛植物感染的情况日益增加,他们对临床批准的药物的抵抗是人类的主要关注点。 在市场上提供各种类别的抗真菌药物,用于治疗这些感染,但不幸的是,他们都没有能够治疗感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号